Ellison Mark Jason Heath 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Jan 31, 2023
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2023-01-27$20.26/sh−610$12,359→ 18,751 total
Footnotes (1)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.